MeSH term
Frequency | Condition_Probility | Adolescent | 3 | 0.0 |
Adult | 3 | 0.0 |
Age of Onset | 2 | 0.0 |
Aged | 2 | 0.0 |
Alleles | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Female | 12 | 0.0 |
Humans | 21 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Male | 13 | 0.0 |
Middle Aged | 2 | 0.0 |
Mutation, Missense | 2 | 0.0 |
N-Acetylglucosaminyltransferases/*genetics | 3 | 16.0 |
Pedigree | 10 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Proteins/*genetics | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 3 | 1.0 |
Chromosomes, Human, Pair 8/genetics | 3 | 3.0 |
Mutation/*genetics | 3 | 0.0 |
Phenotype | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 3 | 0.0 |
Genes, Tumor Suppressor/genetics | 2 | 1.0 |
Amino Acid Sequence | 5 | 0.0 |
Animals | 4 | 0.0 |
Exostoses, Multiple Hereditary/*genetics/pathology | 2 | 40.0 |
Gene Expression | 2 | 0.0 |
Mice | 3 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
*N-Acetylglucosaminyltransferases | 9 | 23.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
*Linkage (Genetics) | 3 | 0.0 |
Exons | 4 | 0.0 |
Exostoses, Multiple Hereditary/*genetics | 10 | 27.0 |
Frameshift Mutation | 2 | 0.0 |
Introns | 3 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Chromosomes, Human, Pair 8 | 2 | 1.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
*Chromosomes, Human, Pair 11 | 5 | 0.0 |
*Chromosomes, Human, Pair 8 | 4 | 1.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Sequence Deletion | 4 | 0.0 |
Chromosomes, Human, Pair 19/genetics | 2 | 1.0 |
*Genetic Heterogeneity | 2 | 1.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Exostoses, Multiple Hereditary/complications/*genetics | 2 | 100.0 |
Genetic Markers | 3 | 0.0 |
Heterozygote | 3 | 0.0 |
Lod Score | 2 | 0.0 |
